» Articles » PMID: 39817709

Prevalence of Posttraumatic Stress Disorder (PTSD) in Canada During the COVID-19 Pandemic: Results from the Survey on COVID-19 and Mental Health

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: This study provides a descriptive overview of the prevalence of posttraumatic stress disorder (PTSD) in Canada, across sociodemographic characteristics, mental health-related variables and negative impacts of the COVID-19 pandemic.

Methods: Data were obtained from cycles 1 and 2 of the Survey on COVID-19 and Mental Health (SCMH), collected in fall 2020 (N = 14 689) and spring 2021 (N = 8032). The prevalence of PTSD was measured using the PTSD Checklist for DSM-5 (PCL-5) Cross-sectional associations were quantified using logistic regression, while controlling for sociodemographic characteristics.

Results: The overall prevalence of PTSD was 6.9%. Factors associated with higher PTSD prevalence were female gender; younger age; lower income (females only); living in an urban area; frontline worker status or not being at work in the past week (males only); fair or poor mental health; a weak sense of community belonging; symptoms of generalized anxiety disorder and major depressive disorder; suicidal ideation; heavy alcohol use; daily cannabis use; increased alcohol and cannabis use since the start of the pandemic; decreased alcohol consumption since the start of the pandemic (males only); concerns about violence in the home; and negative impacts of the pandemic.

Conclusion: PTSD prevalence in Canada varies significantly across sociodemographic groups and is more common among those with indicators of lower mental health and well-being, as well as those more adversely affected by the COVID-19 pandemic. Ongoing and enhanced surveillance of PTSD in Canada is important to better understand and address the burden and impacts of this condition.

References
1.
Kessler R, Sonnega A, Bromet E, Hughes M, Nelson C . Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995; 52(12):1048-60. DOI: 10.1001/archpsyc.1995.03950240066012. View

2.
Hong S, Kim H, Park M . Impact of COVID-19 on post-traumatic stress symptoms in the general population: An integrative review. Int J Ment Health Nurs. 2021; 30(4):834-846. PMC: 8250702. DOI: 10.1111/inm.12875. View

3.
Vig K, Mason J, Carleton R, Asmundson G, Anderson G, Groll D . Mental health and social support among public safety personnel. Occup Med (Lond). 2020; 70(6):427-433. PMC: 7566747. DOI: 10.1093/occmed/kqaa129. View

4.
Koenen K, Ratanatharathorn A, Ng L, McLaughlin K, Bromet E, Stein D . Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med. 2017; 47(13):2260-2274. PMC: 6034513. DOI: 10.1017/S0033291717000708. View

5.
Lee J, Brook J, Finch S, Brook D . Trajectories of cannabis use beginning in adolescence associated with symptoms of posttraumatic stress disorder in the mid-thirties. Subst Abus. 2017; 39(1):39-45. PMC: 5797512. DOI: 10.1080/08897077.2017.1363121. View